Hikal (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Hikal Limited |
|||
|
Price: ₹378.40 | ||
| 52 Week Low: ₹260.30 52 Week High: ₹464.75 |
|||
| Market Capital: 4,768.04 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Hikal Share Price Target For 2024
- 1.1.1: Hikal Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Hikal Share Price Target For 2025
- 1.2.1: Hikal Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Hikal Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Hikal Brief Company Overview
- 4: Hikal Financial Performance
- 4.0.1: Is Hikal A Good Buy For Long Term?
To predict the Hikal's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Hikal Share Price Target For 2024
The line chart displays the monthly closing prices of Hikal with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Hikal shares in 2024, see the table below.
Hikal Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 398.79 (+5.38%) | Price Action: 26 Nov 2024 High |
| 2024 Target 2 | 394.45 (+4.24%) | Price Action: 27 Nov 2024 High |
| 2024 Target 1 | 389.89 (+3.03%) | Price Action: 06 Nov 2024 High |
| Current Price | 378.40 | Hikal's share price as of 20 Dec 2024 |
| Stop Loss 1 | 369.05 (-2.48%) | Price Action: Jun 2021 Low |
| Stop Loss 2 | 364.33 (-3.72%) | Price Action: Aug 2024 High |
| Stop Loss 3 | 359.5 (-5.00%) | Price Action: 28 Oct 2024 High |
Short-Term Technical Outlook
Current Technical Position: Hikal is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹388.53 serves as the nearest technical reference point.
Historical Returns: 3-month: +1.84% | 6-month: +13.55% | 1-year: +24.98%
Hikal Share Price Target For 2025
The line chart displays the monthly closing prices of Hikal with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Hikal shares in 2025, see the table below.
Hikal Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 523.65 (+38.38%) | Price Action: Chart |
| 2025 Target 2 | 513.89 (+35.80%) | Price Action: Chart |
| 2025 Target 1 | 508.8 (+34.46%) | Fibonacci Extension Level 64.90% |
| Current Price | 378.40 | Hikal's share price as of 20 Dec 2024 |
| Stop Loss 1 | 342.27 (-9.55%) | Price Action: Mar 2022 Low |
| Stop Loss 2 | 338.35 (-10.59%) | Technical Indicator: MA200 |
| Stop Loss 3 | 334.35 (-11.65%) | Price Action: Oct 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Hikal is currently trading at 57.8% of its 52-week range (₹260.3 - ₹464.75).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +24.98% | 3-year: -27.29% | 5-year: +242.91%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Hikal Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹378.40 | ||
| 2024 | ₹476.58 | +25.95% | ₹483.73 |
| 2025 | ₹574.13 | +20.47% | ₹582.74 |
| 2026 | ₹712.59 | +24.12% | ₹760.08 |
| 2027 | ₹939.04 | +31.78% | ₹999.17 |
| 2028 | ₹1,218.93 | +29.81% | ₹1,237.21 |
| 2029 | ₹1,379.01 | +13.13% | ₹1,399.70 |
| 2030 | ₹1,362.64 | -1.19% | ₹1,477.35 |
| 2031 | ₹1,480.38 | +8.64% | ₹1,716.44 |
| 2032 | ₹1,771.44 | +19.66% | ₹1,955.52 |
| 2033 | ₹2,136.72 | +20.62% | ₹2,194.61 |
| 2034 | ₹2,281.45 | +6.77% | ₹2,315.67 |
| 2035 | ₹2,151.16 | -5.71% | ₹2,433.70 |
| 2036 | ₹2,248.18 | +4.51% | ₹2,672.79 |
| 2037 | ₹2,603.84 | +15.82% | ₹2,911.88 |
| 2038 | ₹3,054.51 | +17.31% | ₹3,150.96 |
| 2039 | ₹2,843.09 | -6.92% | ₹2,901.57 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Hikal Brief Company Overview
Hikal Limited: A Leading Chemical Manufacturer Hikal Limited is a renowned manufacturer of various chemical intermediates, specialty chemicals, and active pharma ingredients, catering to industries like pharmaceuticals, animal health, and crop protection. Key Products and...
Services: Pharmaceuticals: APIs for drug production Crop Protection: Pesticides and herbicides Other: Contract research, custom synthesis, healthcare products History and Market Presence: Incorporated in 1988, Hikal has a strong global presence in over 80 countries, including the US, Europe, and Japan. Reputation and Commitment: Hikal is highly respected in the industry for its commitment to innovation, quality, and sustainability.Hikal Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 4,768.04 Crore | Market valuation of Hikal's shares. |
| Revenue (TTM) | 1,803.39 Crore | Total revenue generated by Hikal over the past twelve months. |
| Net Income (TTM) | +678,000,000.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +6.44% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +3.76% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+4.80% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-26.30% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
68.84 | Company's total debt divided by total shareholder equity. |
| Total Debt | 817.57 Crore | Sum of Hikal's current & long-term financial obligations. |
| Total Cash | 20.88 Crore | Total amount of liquid funds available to Hikal. |
| Beta | 1.25 | Beta is greater than 1 indicating that the Hikal's price is more volatile than the market. |
Is Hikal A Good Buy For Long Term?
Hikal, a small-cap stock with a market capitalization of ₹4,768.04 crore, shows mixed signals for long-term investment. While its past performance is impressive (137.35% return over 3 years, 150.02% over 5 years), Q2 2024-25 results reveal a concerning -26.3% year-on-year earnings decline and a meager 3.76% profit margin. The substantial debt of ₹817.57 crore against a low cash balance of ₹20.88 crore raises red flags. Therefore, despite recent positive returns, Hikal is currently a risky investment, and a more cautious approach is advised for long-term investors.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
